These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 301104)

  • 21. [Aprotinin and the cardiovascular system].
    Rossi F; Brita G; Alfano C; Lampa E; Del Vecchio F; Apolito A
    Arch Sci Med (Torino); 1977; 134(4):337-58. PubMed ID: 305772
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of kinins on the action of circulatory drugs. I. The influence of kinins on hypertensive and hypotensive effects of selected drugs.
    Moniuszko-Jakoniuk J; Wiśniewski K; Radwan J
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):497-501. PubMed ID: 999466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein-kinin system in the angiogenesis.
    Ferreira MA; Andrade SP; Pesquero JL; Feitosa MH; Oliveira GM; Rogana E; Nogueira JC; Beraldo WT
    Agents Actions Suppl; 1992; 38 ( Pt 2)():165-74. PubMed ID: 1281370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood.
    Pojda SM; Vane JR
    Br J Pharmacol; 1971 Aug; 42(4):558-68. PubMed ID: 5315684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular system reactivity to catecholamines during ontogenetic development of dogs and rats.
    Brus R; Lenartowicz H; Korczak-Dziuba K; Monsiol A; Kmieciak-Kolada K; Jamrozik Z
    Acta Physiol Pol; 1975; 26(6):543-51. PubMed ID: 1108594
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular effects of 15(S) 15 methyl-PGF2 alpha.
    Filippelli W; Filippelli A; Caloprice A; Vacca C; Bile G; Spadaro R; Marmo E
    J Med; 1982; 13(5-6):387-98. PubMed ID: 6963330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reflex cardiocirculatory and respiratory responses caused by bradykinin injections into the femoral and carotid circulatory areas].
    Tallarida G; Baldoni F; Peruzzi G; Sangiorgi M
    Boll Soc Ital Biol Sper; 1973 Feb; 49(3):79-84. PubMed ID: 4786553
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for presence of adrenergic receptors in the 6-day-old chick embryo.
    St Petery LB; Van Mierop LH
    Am J Physiol; 1974 Dec; 227(6):1406-10. PubMed ID: 4155250
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of kallikrein (K), bradykinin (B) and insulin (I), on substrate metabolism in the isolated perfused rat heart.
    Rett K; Maerker E; Lodri C; Wicklmayr M; Dietze G
    Adv Exp Med Biol; 1986; 198 Pt B():379-84. PubMed ID: 2433914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of the activation of the kinin-forming system on the potency of chlorpromazine.
    Moniuszko-Jakoniuk J; Wiśniewski K; Bodzenta A
    Pharmacology; 1974; 12(4-5):216-23. PubMed ID: 4548757
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison in conscious and anaesthetized dogs of the effect on blood pressure of bradykinin, kallidin, eledoisin and kallikrein.
    Pearson L; Lang WJ
    Eur J Pharmacol; 1967 Nov; 2(2):83-7. PubMed ID: 5583434
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of trasylol. Evaluation of trasylol against the hypotensive effects of trypsin and kallikrein.
    Singh LM; Howard JM
    Arch Surg; 1965 Oct; 91(4):635-9. PubMed ID: 5294444
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of the kallikrein-kinin system on gastric mucosa].
    Dorofeev GI; Vasil'ev VIu; Tkachenko EI; Leshchenko NM
    Fiziol Zh SSSR Im I M Sechenova; 1984 Apr; 70(4):468-71. PubMed ID: 6329831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of angiotensin, norepinephrine, and bradykinin continuously measured in unanesthetized dogs.
    PAGE IH; OLMSTED F
    Am J Physiol; 1961 Jul; 201():92-6. PubMed ID: 13732020
    [No Abstract]   [Full Text] [Related]  

  • 39. Generation of angiotensin II from human plasma by tissue kallikrein.
    Krivoy N; Schlüter H; Karas M; Zidek W
    Clin Sci (Lond); 1992 Oct; 83(4):477-82. PubMed ID: 1385031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble dextran complexes of kallikrein. Bradykinin and enzyme inhibitors.
    Odya CE; Levin Y; Erdös EG; Robinson CJ
    Biochem Pharmacol; 1978 Jan; 27(2):173-9. PubMed ID: 203289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.